Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats

British Journal of Pharmacology

Volumn 166, Issue 6, 2012, Pages 1815-1821

  Jones, E K ^a   Kirkham, Tim C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Appetite; Break point; Cannabinoid; Feeding; Hyperphagia; Obesity; Orexigen; Progressive ratio; Surinabant; Wanting

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; NOLADIN ETHER; SURINABANT;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; APPETITE; ARTICLE; BEHAVIOR CONTROL; EATING HABIT; FOOD INTAKE; HYPERPHAGIA; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; EATING; ENDOCANNABINOIDS; GLYCERIDES; HYPERPHAGIA; MALE; MOTIVATION; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1;

EID: 84862775708     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01888.x     Document Type: Article

References (47)

1. Alexander SPH, Mathie A, Peters JA (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Arnone M, Maruani J, Chaperon F, Thiébot M, Poncelet M, Soubrié P et al. (1997). Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132: 104-106. (Pubitemid 27303746)
3. Avraham Y, Ben Menachem A, Okun A, Zlotarav O, Abel N, Mechoulam R et al. (2005). Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull 65: 117-123. (Pubitemid 40348796)
4. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63: PL113-PL117.
5. Di Marzo V, Matias I (2005). Endocannabinoid control of food intake and energy balance. Nat Neurosci 8: 585-589. (Pubitemid 40594198)
6. Di Patrizio NV, Simansky KJ (2008). Activating parabrachial cannabinoid CB1 receptors selectively stimulate feeding of palatable foods in rats. J Neurosci 28: 9702-9709.
7. Doggrell SA (2005). Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opin Investig Drugs 14: 339-342.
8. 9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behav Pharmacol 21: 769-772.
9. Fezza F, Bisogno T, Minassi A, Appendino G, Mechoulam R, Di Marzo V (2002). Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett 513: 294-298. (Pubitemid 34251281)
10. Fride E, Bregman T, Kirkham TC (2005). Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp Biol Med (Maywood) 230: 225-234. (Pubitemid 40478246)
11. Gallate JE, McGregor IS (1999). The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berl) 142: 302-308. (Pubitemid 29200158)
12. Gallate JE, Saharov T, Mallet PE, McGregor IS (1999). Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 370: 233-240. (Pubitemid 29192867)
13. Gessa GL, Serra S, Vacca G, Carai MA, Colombo G (2005). Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 40: 46-53.
14. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE et al. (2001). 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A 98: 3662-3665. (Pubitemid 32249827)
15. Hao S, Avraham Y, Mechoulam R, Berry EM (2000). Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392: 147-156. (Pubitemid 30184903)
16. Hayase T, Yamamoto Y, Yamamoto K (2005). Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav Pharmacol 16: 395-404. (Pubitemid 41404811)
17. 9-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165: 370-377.
18. Higgs S, Barber DJ, Cooper AJ, Terry P (2005). Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats. Behav Pharmacol 16: 389-393. (Pubitemid 41404810)
19. Hodos W (1961). Progressive ratio as a measure of reward strength. Science 134: 943-944.
20. Jamshidi N, Taylor DA (2001). Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134: 1151-1154. (Pubitemid 33097243)
21. 9- tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test. Physiol Behav 86: 475-479.
22. Kirkham TC (2005). Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16: 297-313.
23. Kirkham TC (2009). Endocannabinoids and the non-homeostatic control of appetite. Curr Top Behav Neurosci 1: 231-253.
24. Kirkham TC, Rogers EK (2010). Endocannabinoids in the aetiopathology of obesity - central mechanisms. Drug Discov Today Dis Mech 7: e163-e168.
25. Kirkham TC, Williams CM (2001a). Endocannabinoids: neuromodulators of food craving? In: Hetherington M (ed.). Food Cravings and Addiction. Leatherhead Publishing: Leatherhead, Surrey, pp. 85-120.
26. Kirkham TC, Williams CM (2001b). Endogenous cannabinoids and appetite. Nutr Res Rev 14: 65-86. (Pubitemid 32574404)
27. Kirkham TC, Williams CM (2004). Endocannabinoid receptor antagonists. Treat Endocrinol 3: 1-16.
28. Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002). Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136: 550-557. (Pubitemid 34717699)
29. Mahler SV, Smith KS, Berridge KC (2007). Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 32: 2267-2278. (Pubitemid 47587687)
30. Mechoulam R, Hanus E, Fride E (1998). Towards cannabinoid drugs: revisited. Prog Med Chem 35: 199-243.
31. Mechoulam R, Berry EM, Avraham Y, Di Marzo V, Fride E (2006). Endocannabinoids, feeding and suckling - from our perspective. Int J Obes 30: S24-S28.
32. Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H et al. (2003). Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem 85: 1374-1381. (Pubitemid 36702550)
33. Páldyová E, Bereczki E, Sántha M, Wenger T, Borsodi A, Benyhe S (2008). Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors. Neurochem Int 52: 321-328. (Pubitemid 350235710)
34. Richardson D, Ortori CA, Chapman V, Kendall DA, Barrett DA (2007). Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal Biochem 360: 216-226. (Pubitemid 44958332)
35. Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A et al. (2004). SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N- (1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 310: 905-914. (Pubitemid 39108910)
36. Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R (2004). Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl) 176: 223-232. (Pubitemid 39517952)
37. Simiand J, Keane M, Keane P, Soubrié P (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179-181. (Pubitemid 28186515)
38. Solinas M, Goldberg SR (2005). Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 30: 2035-2045. (Pubitemid 43093503)
39. Soria-Gómez E, Matias I, Rueda-Orozco PE, Cisneros M, Petrosino S, Navarro L et al. (2007). Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. Br J Pharmacol 151: 1109-1116. (Pubitemid 47195529)
40. Steffens M, Zentner J, Honegger J, Feuerstein TJ (2005). Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor. Biochem Pharmacol 69: 169-178. (Pubitemid 39592883)
41. Touriño C, Oveisi F, Lockney J, Piomelli D, Maldonado R (2010). FAAH deficiency promotes energy storage and enhances the motivation for food. Int J Obes 34: 557-568.
42. 9-tetrahydrocannabinol. Neuropharmacology 49: 1101-1109.
43. Wakley AA, Rasmussen EB (2009). Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats. Pharmacol Biochem Behav 94: 30-36.
44. Williams CM, Kirkham TC (1999). Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 143: 315-317. (Pubitemid 29204987)
45. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 7: 333-340.
46. 9-THC and anandamide. Physiol Behav 76: 241-250.
47. 9-THC. Physiol Behav 65: 343-346.